| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 02/07/2008 | WO2008015240A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | WO2005046568A3 Process for manufacture of metoprolol and salts thereof |
| 02/07/2008 | US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 02/07/2008 | US20080033024 Aryl amino acid derivatives as inhibitors for treating inflammation |
| 02/07/2008 | CA2658547A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/06/2008 | CN101119963A Methamphetamine derivatives and conjugates for immunoassay |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 01/31/2008 | WO2008012283A1 Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine |
| 01/31/2008 | WO2008012047A1 Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027075 Quaternary Amino-Function Chalcones |
| 01/31/2008 | CA2657104A1 Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 01/31/2008 | CA2656696A1 Preparation of (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpentanamine |
| 01/30/2008 | CN100364961C Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof |
| 01/29/2008 | US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/29/2008 | CA2220999C Process for the hydrogenation of imines |
| 01/24/2008 | WO2008010481A1 Aminoindan derivative or salt thereof |
| 01/24/2008 | US20080021244 Levalbuterol hydrochloride Polymorph A |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | DE102006031143A1 Fluortenside Fluorosurfactants |
| 01/23/2008 | CN101111472A Tetralin and indane derivatives and uses thereof |
| 01/23/2008 | CN101108791A Substituted benzyl ethylene derivant and method of preparing the same and use thereof |
| 01/22/2008 | US7321065 E.g., N-methyl-O-benzyl-tyramine, 3,5,3',5'-tetraiodothyroethanolamine; antagonist of a G protein coupled receptor and a trace amine receptor; antidepressants; nervous system disorders; antidiabetic agents; antiarrhymia disorders; glandular disorders of the thyroid; congestive heart failure; analgesics |
| 01/22/2008 | CA2172946C N-(.alpha.-alkylbenzylidene)-.alpha.-phenylalkylamine, its use and process for producing the same and process for producing intermediate |
| 01/17/2008 | WO2008006754A1 Method for producing an amine |
| 01/17/2008 | WO2008006752A1 Method for producing an amine |
| 01/17/2008 | WO2008006750A1 Method for producing an amine |
| 01/17/2008 | WO2008006749A1 Method for producing an amine |
| 01/17/2008 | WO2008006627A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/17/2008 | US20080015258 Dissolving moprolol and tartaric acid in a 2:1 molar ratio in ethanol, precipitating and filtering; gels ointments, eyedrops; glaucoma; improved tolerability over hydrochloride salt |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | CA2657006A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/16/2008 | EP1878719A1 Crystal polymorph of hydroxynorephedrin derivative hydrochloride |
| 01/16/2008 | EP1878718A1 Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate |
| 01/16/2008 | EP1877367A1 Acetylene derivatives |
| 01/15/2008 | US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7318964 Luminescent material for organic and polymer-based electro-luminescence element and other optical elements |
| 01/10/2008 | WO2008004115A1 Process for preparing gabapentin |
| 01/10/2008 | CA2660769A1 Process for preparing gabapentin |
| 01/09/2008 | EP1876167A1 Crystal polymorphism of 4 -{2-ý(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino¨ethoxy}-3-isopropyl-3 ,5 -dimethylbiphenylcarboxylic acid hydrochloride |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/08/2008 | US7317023 Diaryl ether β2 adrenergic receptor agonists |
| 01/08/2008 | CA2373315C Method of polymerization |
| 01/08/2008 | CA2267315C Ethylamine derivatives |
| 01/03/2008 | WO2008002817A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | US20080004471 Dendrimers |
| 01/03/2008 | US20080004470 Synthesis of Atomoxetine Hydrochloride |
| 01/03/2008 | US20080004362 Hydroxyalkylated Polyalkylenepolyamine Composition, Method for Producing Same and Method for Producing Polyurethane Resin Using Such Hydroxyalkylated Polyalkylenepolyamine Composition |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | CA2656075A1 Butyl and butynyl benzyl amine compounds |
| 01/02/2008 | EP1873181A2 Curing agent for epoxy resin and coating composition |
| 01/02/2008 | EP1458743B1 Tetrahydrobenzfluorene derivatives |
| 01/02/2008 | CN101096344A Organic electroluminescence device and phenylenediamine derivative |
| 01/02/2008 | CN100358861C Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007147866A1 Process for preparation of alkoxylated alkylamines / alkyl ether amines with peaked distribution |
| 12/27/2007 | WO2007147564A1 Process for preparation of 0-desmethylvenlafaxine and its analogues |
| 12/27/2007 | WO2007086883A3 Cationic lipids and formulated molecular compositions containing them |
| 12/27/2007 | CA2656429A1 Process for preparation of alkoxylated alkylamines / alkyl ether amines with peaked distribution |
| 12/26/2007 | EP1870395A1 Process for preparation of o-desmethylvenlafaxine and its analogue |
| 12/26/2007 | EP1868986A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 12/26/2007 | CN101094827A Benzene compound having two or more substituents |
| 12/26/2007 | CN101092366A Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochlorid, processes for preparing thereof |
| 12/26/2007 | CN100357329C Method of polymerization |
| 12/25/2007 | US7312368 Reacting halogen and hydroxy substituted aromatic compounds with an alkali metal or in a nitrogen base and an alcohol; hydroxyl group prevents dehalogenation; selectively retaining a halogen group on an aromatic ring |
| 12/25/2007 | US7312360 Substituted hydroxyethylamines |
| 12/25/2007 | US7312343 N-benzyl-protected dialkyl acetal derivatives undergo desired aldol reaction with high diastereoselectivity using a Mukaiyama aldol reaction; intermediates in the synthesis of other products, including, e.g. Dolastatin 10 |
| 12/21/2007 | WO2002072068A3 Lipids, lipid compositions, liposomes, and lipoplexes |
| 12/20/2007 | US20070293705 Acylating a sulfonic acid with an alkyl- or arylacyl halide, anhydride or diphenylketene; reacting product with a dioxane, amination, and hydrolysis; 2-(2-t-butylaminoethoxy)ethanol from p-toluenesulfonic acid; acetyl chloride, acetic anhydride or diphenyl; 1,4-dioxane; and tert-butylamine |
| 12/20/2007 | US20070293548 Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
| 12/19/2007 | EP1628648B1 Deramciclane-fumarate tablets |
| 12/19/2007 | EP1497261B1 Phenethanolamine derivatives |
| 12/19/2007 | EP1313560B1 CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION |
| 12/19/2007 | EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 12/19/2007 | CN101090904A Enantioselective phosphoramidite compounds and catalysts |
| 12/19/2007 | CN101090883A Substituted hydroxyethylamines |
| 12/19/2007 | CN101090882A P-diaminobenzene derivatives and dyes containing these compounds |
| 12/19/2007 | CN100355491C Waterpower liquid |
| 12/13/2007 | WO2007140662A1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof |
| 12/13/2007 | CA2640876A1 Process for the preparation of metoprolol and its salts |
| 12/12/2007 | CN101085744A Fluorine-containing aromatic diaminomonomer and synthetic method thereof |
| 12/12/2007 | CN101085743A Fluorine-containing alkoxy combretastatin derivative, preparation method and use thereof |
| 12/12/2007 | CN101085742A Technique for synthesizing levorotatory betaxolol hydrochloride |
| 12/12/2007 | CN100354981C Composition for polyelectrolytes, polyelectrolytes, electrical double layer capacitors and nonaqueous electrolyte secondary cells |
| 12/06/2007 | WO2007139923A1 Deuterated aminoglycidyl compounds |
| 12/06/2007 | WO2007107828A3 Amine derivatives |
| 12/06/2007 | CA2653209A1 Deuterated aminoglycidyl compounds |
| 12/05/2007 | CN101081819A 1,4-bis(4-amino-benzene oxymethylene) cyclohexyl and preparation and application thereof |
| 12/05/2007 | CN101081818A Preparation method for methoxyaniline by highly-selective catalytic hydrogenation of methoxyl nitro compound |
| 12/05/2007 | CN100352431C Pharmaceutical salts |
| 12/04/2007 | US7304174 CaSR antagonist |
| 12/04/2007 | US7304155 Nonsteroid; enantiomers are selective antagonists of the estrogen beta receptor relative to the alpha receptor; tissue selectivity; fewer estrogen-related side effects; menopause, osteoporosis, hormone replacent therapy, contraceptive, endometriosis; 10-aminoalkyloxyphenyl benzo[b]fluorene 2,8-diols |
| 12/04/2007 | US7303792 Carbocyclic or heterocyclic ether of 5-methylol-1,3-phenylenediamine, e.g., 5-(p-octyloxybiphenoxymethyl)-1,3-phenylenediamine; liquid crystal alignment film having a high pretilt angle of liquid crystal, excellent thermal stability and small dependence of the pretilt angle on rubbing pressure |
| 11/29/2007 | WO2007134666A1 Fragrance precursor |
| 11/29/2007 | WO2007134421A1 2-VINYL INDOLES, PYRIDO AND AZEPINO INDOLE DERIVATIVES, 2-ALKYNYL INDOLES, 2-ALKYNYL BENZO[b]FURANS, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF |
| 11/29/2007 | WO2007045893A3 Beta adrenergic receptor pharmacophore |
| 11/29/2007 | US20070276162 Catalytic Preparation of Severely Sterically Hindered Amino-Ether Alcohols Using a Metal Loaded Catalyst |